skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

ファーマインテリジェンスが選ばれる理由

business Intelligence sales forecasts pharma intelligence

世界有数の医薬品業界情報プロバイダー

日々激しさを増す医薬品・医療機器市場において、質の高い医薬品業界ニュースやマーケット分析をグローバルで提供する世界有数の情報プロバイダーです。

news and insight analyst page expertise in all areas pharma intelligence

リアルタイムのニュース配信サービス

世界中のアナリストがリアルタイムの医薬品業界ニュースを毎日配信します。事実の報道だけでなく、グローバルな視点で独自の分析と見解をご提供します。

data and analysis indepth company profiles pharma intelligence

確固たるデータに基づいた分析

当社が提供する分析は、175か国、4万2千社による24万8千件の臨床試験、および、1400種の疾病に対する6万5千の医薬品データに基づいています。

consultancies pharma intelligence

オーダーメードのプロジェクトもご提供

顧客企業ごとのビジネスニーズに対応する実用的なコンサルテーションサービスをご提供します。投資利益率向上のためにお客様の組織を内側から支えます。

ask the analyst pharma intelligence

世界規模の視点が強み医薬専門のアナリスト

300名超の専属アナリストと65名のジャーナリストが、世界中の製薬業界情報を網羅します。

dedicated account manager pharma intelligence

3000社以上のお客様と取引実績

当社は世界の製薬会社トップ50社および医薬品開発業務受託機関(CRO)の上位10社を含む3000社以上のお客様にサービスをご提供してきました。

 

gold standard service product developments pharma intelligence

顧客第一のカスタマーサポート

ニュース配信サービスから調査・分析業務、コンサル等のカスタマイズサービスまで。カスタマーサポートがお客様のお問合せに一つ一つ丁寧に対応します。

solution to suity our need epidemiology pharma intelligence

一人ひとりのお客様に最適なソリューション

分析レポート単体の購入から法人単位の購読契約やコンサル案件まで。各お客様のニーズにしっかり向き合います。

ファーマインテリジェンスが提供するサービスブランド

Biomedtracker
DMHC
In Vivo
Meddevicetracker
Medtech-Insight
Medtrack
Pharma consulting
Pharmapremia
Pharmaprojects
Pink Sheet
RxScorecard
Scrip
Sitetrove
Trialtrove

メールサービスの最新記事

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    Brexit Implications for Pharma Article Pack

    22 Jun 2018

    Are you prepared for Brexit and what it could mean for your business? In a few short months, the interim period will end and the UK will depart from the European Union, leaving uncertainty in its wake. How can you prepare for this unprecedented event? Informa Pharma Intelligence has prepared an article pack covering Brexit and the topics discussed at the recent Drug Information Association (DIA) Europe meeting, and it is now available to you – for free.

    Topic Policy and regulation

  • Medtech Insight:世界の医療機器に特化したニュース配信

    SOPHiA Buys In More Bioinformatics Know-How For Cancer Genomics

    By Catherine Longworth 21 Jun 2018

    In a move to accelerate adoption of its AI-driven genomics platform, SOPHiA Genetics has acquired Interactive Biosoftware, the French developer of Alamut, a clinical decision support software used in  genomic data interpretation.

    Topic Company analysis Digital Health Business strategies

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    Sarepta Should Gain Clean Slate With CBER Review of DMD Gene Therapy

    21 Jun 2018

    Sarepta will face a US FDA staff with which it does not have a controversial history, the Center for Biologics Evaluation and Research, likely avoiding the reviewers that evaluated its Duchenne muscular dystrophy treatment Exondys 51.

    Topic Diseases

  • Pink Sheet:世界の薬事規制と承認審査に関するニュース

    UK Industry Raises Conflict of Interest Concerns Over NICE’s PRIMA Service

    By Francesca Bruce 21 Jun 2018

    PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be affected by confidentiality and conflict of interest issues, warns UK the pharmaceutical industry group, ABPI.

    Topic Business strategies

  • Medtech Insight:世界の医療機器に特化したニュース配信

    Mock Audits: Has Ambiguity In EU Led To Unfair Advantage?

    21 Jun 2018

    There's been confusion and conflicting opinions about notified bodies conducting mock audits on companies' documentation to prove conformity with the impending EU Medical Device and IVD Regulations. Has the lack of clarity led to different and unfair practices? Does it matter?

    Topic Medtech

  • Scrip:世界の医薬品産業ニュースサービス

    ADA Meeting's Around The Corner: Five Things To Watch For

    By Emily Hayes 21 Jun 2018

    Among other debates at the American Diabetes Association annual meeting, clinicians will discuss the future of cardiovascular outcomes studies for diabetes drugs – whether they should maintain course or are due for an overhaul.

    Topic Diabetes

  • Scrip:世界の医薬品産業ニュースサービス

    Learning From Human Cell Hijacking Masters: ENYO Pharma Takes Virus Tricks Into Drug Discovery

    21 Jun 2018

    Emerging Company Profile: ENYO Pharma has been around for barely four years, but it is already advancing its lead programs into Phase II trials in hepatitis B and NASH, and anticipates many more uses for its virology-based platform that will go way beyond treating virus infections.

    Topic Company analysis Hepatitis B

  • awareness

    Global Generics Podcast 2018

    20 Jun 2018

    Listen to this podcast with Generics bulletin editor Aidan Fry and deputy editor David Wallace. The Global Generics & Biosimilars Awards reward ‘best practice’ in the two industries, while at the same time encouraging improvements in every aspect of the way business is conducted.

  • Biomedtracker

    Regenerative Medicine Advanced Therapy Webinar

    19 Jun 2018

    Gain a deeper understanding of the implications of the Regenerative Medicine Advanced Therapies (RMAT) designation and the significance of its support and advancement by the FDA in this webinar recording, "RMAT Designation – Impact on Regenerative Medicine Sector".

    Topic Drug development landscape

  • awareness

    Acute Myeloid Leukemia Market Outlook Seminar

    19 Jun 2018

    There has been little change to standard treatment for AML in recent years; however, 2017 saw a flurry of new targeted drug approvals, sparking significant market growth. Patient age remains the biggest factor in driving treatment decisions for AML. Cases of AML are expected to increase, and prognosis remains poor – especially among older adults. Drug developers are targeting patient segments with high unmet clinical need to gain access to the AML market and the budget impact of AML is expected to grow considerably.

    Topic Cancer

  • awareness

    Trends in Gene Therapy Seminar

    By Patricia Reilly 19 Jun 2018

    The promises of gene therapy are taking a long time to be fulfilled, in part due to challenges in developing gene vectors capable of safe and efficient delivery of therapeutic genes (transgenes) into patients’ cells. Nonetheless, these challenges are being addressed in innovative ways. A variety of first-generation vectors, both viral and non-viral, have been employed in clinical trials with varying degrees of success, and the experience gained is guiding the design of next-generation vectors.

  • Meddevicetracker

    Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications

    By tina-tan 15 Jun 2018

    The webinar will provide a thought leadership perspective on the key challenges and trends in the emerging Robotic Surgery market.

    Topic Digital Health Research

  • Medtech Insight:世界の医療機器に特化したニュース配信

    Procept BioRobotics Believes Aquablation Could Dominate BPH Treatment... If It Gets Coverage

    14 Jun 2018

    Results of the WATER II trial confirm that Aquablation is a safe and effective treatment of benign prostate hyperplasia for large prostates, and manufacturer Procept BioRobotics is confident the procedure will eventually displace all other prostate resection techniques because it is easy for surgeons to learn.

    Topic Company analysis Business strategies

  • In Vivo : 医薬品・医療機器業界の経営層を対象としたニュース

    World In Motion The Shape Of The New Health Care Technology Ecosystem In 2022

    By Ashley Yeo 14 Jun 2018

    The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.

    Topic Business strategies Digital Health

  • In Vivo : 医薬品・医療機器業界の経営層を対象としたニュース

    How The EHR And New Data Streams Are Influencing Clinical Practice

    By Mark Ratner 14 Jun 2018

    A plethora of clinical studies are showing that new types of data, often captured in the EHR, can help improve the correlation between treatments and outcomes and favorably affect patient care as well as enhance drug development.

関連する製品

trial trove pharma intelligence

Trialtrove

Key benefits:

  • 専門家による情報精査
  • 世界中の臨床試験情報を網羅
  • 標準治療に関する情報
pdpimage

Datamonitor Healthcare

Key benefits:

  • 市場機会を見極める
  • アンメットニーズを特定
  • データドリブンの意思決定
scrip pharma intelligence

Scrip:世界の医薬品産業ニュースサービス

Key benefits:

  • Scripジャーナリストチーム
  • Go beyond the news
  • Hear from news makers

最新のイベント情報

23 Sep 2018

USA

Awards

Medtech Insight Awards 2018 in Partnership with The MedTech Conference

09 Oct 2018

Spain

Awards

Global Generics & Biosimilars Awards 2018

28 Nov 2018

Awards

Scrip Awards 2018

Keep up to date